JP2012503478A5 - - Google Patents

Download PDF

Info

Publication number
JP2012503478A5
JP2012503478A5 JP2011528171A JP2011528171A JP2012503478A5 JP 2012503478 A5 JP2012503478 A5 JP 2012503478A5 JP 2011528171 A JP2011528171 A JP 2011528171A JP 2011528171 A JP2011528171 A JP 2011528171A JP 2012503478 A5 JP2012503478 A5 JP 2012503478A5
Authority
JP
Japan
Prior art keywords
modified
nucleic acid
genetically engineered
engineered strain
polyketide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011528171A
Other languages
English (en)
Other versions
JP5789190B2 (ja
JP2012503478A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2009/074178 external-priority patent/WO2010034243A1/en
Publication of JP2012503478A publication Critical patent/JP2012503478A/ja
Publication of JP2012503478A5 publication Critical patent/JP2012503478A5/ja
Application granted granted Critical
Publication of JP5789190B2 publication Critical patent/JP5789190B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (5)

  1. 配列番号1の配列に基づいたハイブリッドポリケチド生成遺伝子クラスター核酸であって、sfaAが、さらに任意に、sfaB、J、M、N、P、Q、L、およびOから選択される1つ以上の他の開始単位もしくは前駆体生合成遺伝子が、欠失され、またはその活性を低下させるよう修飾され、またはその基質特異性を変化させるよう修飾もしくは置換されている、前記ハイブリッドポリケチド生成遺伝子クラスター核酸。
  2. 請求項1記載の核酸を1つ以上のプロモーターまたは他の調節エレメントとともに含むベクターであって、前記核酸がDNAである、前記ベクター。
  3. 請求項2記載のベクターを用いて形質転換された宿主細胞。
  4. サングリフェリンA産生株に基づいた遺伝子操作された株であって、sfaAが、さらに任意に、sfaB、J、M、N、P、Q、L、およびOから選択される1つ以上の他の開始単位または前駆体生合成遺伝子が、欠失され、またはその活性を低下させるよう修飾され、またはその基質特異性を変化させるよう修飾もしくは置換されている、前記遺伝子操作された株。
  5. 請求項3または4記載の形質転換された宿主細胞または遺伝子操作された株を培養することを含む、ポリケチドを製造する方法。
JP2011528171A 2008-09-24 2009-09-24 新規の遺伝子クラスター Active JP5789190B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200810200388.4 2008-09-24
CN200810200388 2008-09-24
PCT/CN2009/074178 WO2010034243A1 (en) 2008-09-24 2009-09-24 Novel gene cluster

Publications (3)

Publication Number Publication Date
JP2012503478A JP2012503478A (ja) 2012-02-09
JP2012503478A5 true JP2012503478A5 (ja) 2012-11-08
JP5789190B2 JP5789190B2 (ja) 2015-10-07

Family

ID=42059282

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011528171A Active JP5789190B2 (ja) 2008-09-24 2009-09-24 新規の遺伝子クラスター

Country Status (6)

Country Link
US (1) US8962329B2 (ja)
EP (1) EP2342335B1 (ja)
JP (1) JP5789190B2 (ja)
CN (1) CN102224242B (ja)
ES (1) ES2556211T3 (ja)
WO (1) WO2010034243A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
JP5894935B2 (ja) 2010-02-09 2016-03-30 ニューロヴィベ プハルマセウトイカル エービー サングリフェリン系化合物
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2012085553A1 (en) 2010-12-20 2012-06-28 Biotica Technology Limited Sanglifehrin derivatives and methods for their production
US9428845B1 (en) 2010-12-28 2016-08-30 Warp Drive Bio, Inc. Identifying new therapeutic agents
JO3063B1 (ar) 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
GB201118334D0 (en) 2011-10-24 2011-12-07 Biotica Tech Ltd Novel dosage form
CN104263738A (zh) * 2014-09-15 2015-01-07 武汉大学 Fas ii抑制剂abx的生物合成基因簇
US10533016B2 (en) 2015-01-09 2020-01-14 Revolution Medicines, Inc. Compounds that participate in cooperative binding and uses thereof
TW201629069A (zh) 2015-01-09 2016-08-16 霍普驅動生物科技股份有限公司 參與協同結合之化合物及其用途
US9989535B2 (en) 2015-10-01 2018-06-05 Warp Drive Bio, Inc. Methods and reagents for analyzing protein-protein interfaces
CN106916834B (zh) * 2015-12-24 2022-08-05 武汉合生科技有限公司 化合物的生物合成基因簇及其应用
EP4085933A3 (en) 2016-04-12 2023-01-11 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
AU2017350900A1 (en) 2016-10-28 2019-06-13 Ginkgo Bioworks, Inc. Compositions and methods for the production of compounds
CN109943545B (zh) * 2019-03-29 2021-08-03 浙江大学 一种酰基转移酶结构域定向改造合成化合物的方法
TW202132316A (zh) 2019-11-04 2021-09-01 美商銳新醫藥公司 Ras抑制劑
WO2021091967A1 (en) 2019-11-04 2021-05-14 Revolution Medicines, Inc. Ras inhibitors
KR20220109407A (ko) 2019-11-04 2022-08-04 레볼루션 메디슨즈, 인크. Ras 억제제
CA3194067A1 (en) 2020-09-15 2022-03-24 Revolution Medicines, Inc. Ras inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE206164T1 (de) * 1993-09-20 2001-10-15 Univ Leland Stanford Junior Rekombinante herstellung von neuen polyketiden
AR006514A1 (es) * 1995-07-04 1999-09-08 Sandoz Ag Un macrolido, sus usos, un proceso para producirlo, un aislado biologicamente puro capaz de producirlo, y una composicion farmaceutica quelo comprende
US6124453A (en) 1995-07-04 2000-09-26 Novartis Ag Macrolides
SK182498A3 (en) 1996-07-05 2000-05-16 Biotica Tech Ltd Erythromycins and process for their preparation
US6265202B1 (en) 1998-06-26 2001-07-24 Regents Of The University Of Minnesota DNA encoding methymycin and pikromycin
GB9814622D0 (en) 1998-07-06 1998-09-02 Biotica Tech Ltd Polyketides,their preparation,and materials for use therein
AU2001248588B2 (en) 2000-04-13 2006-02-02 Biotica Technology Limited Hybrid glycosylated products and their production and use
ES2544624T3 (es) 2002-07-16 2015-09-02 Buck Institute For Research On Aging Producción de policétidos
GB0230217D0 (en) 2002-12-27 2003-02-05 Biotica Tech Ltd Borrelidin-producing polyketide synthase and its uses
GB0327720D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Erythromycins and process for their preparation
GB0327721D0 (en) 2003-11-28 2003-12-31 Biotica Tech Ltd Polyketides and their synthesis
AR054778A1 (es) 2005-06-17 2007-07-18 Novartis Ag Uso de sangliferina en hcv

Similar Documents

Publication Publication Date Title
JP2012503478A5 (ja)
WO2013027999A3 (ko) 열 안정성이 향상된 사이코스 에피머화 효소 변이체 및 이를 이용한 사이코스의 연속적 생산
JP2011062217A5 (ja)
GEP201606544B (en) Excision of transgenes in genetically modified organisms
MY157111A (en) Recombinant microorganisms and methods of production thereof
NZ600540A (en) Ethanol production in non-recombinant hosts
WO2013076144A3 (en) Microorganism strains for the production of 2,3-butanediol
JP2007175057A5 (ja)
WO2008093847A1 (ja) キシリトールデヒドロゲナーゼをコードするdna
WO2010104390A3 (en) Preparation of alpha-ketopimelic acid
WO2008126784A1 (ja) グルタチオンおよびγ-グルタミルシステインの製造法
MY164623A (en) Method for producing high amount of glycolic acid by fermentation
JP2009529905A5 (ja)
UA112783C2 (uk) СПОСІБ ОДЕРЖАННЯ ЦЕЛЮЛАЗ З ВИКОРИСТАННЯМ МІЦЕЛІАЛЬНОГО ГРИБА, ПРИДАТНОГО ДЛЯ БІОРЕАКТОРА, ЩО МАЄ НИЗЬКИЙ ОБ'ЄМНИЙ КОЕФІЦІЕНТ ПЕРЕНЕСЕННЯ КИСНЮ kLa
TW201217533A (en) Genomics of actinoplanes utahensis
WO2013065046A8 (en) Isolated polynucleotides and polypeptides, transgenic plants comprising same and uses thereof in improving abiotic stress tolerance, nitrogen use efficiency, biomass, vigor or yield of plants
WO2013105802A3 (ko) 자일로즈 이용능이 부여된 코리네박테리움 속 미생물 및 이를 이용한 l-라이신의 생산방법
EP2551345A4 (en) VARIANT OF HCV WITH HIGH PRODUCTIVITY OF INFECTIOUS HEPATITIS C VIRUSES AND USE THEREOF
WO2013030176A3 (en) Live attenuated influenza virus
WO2013085361A3 (ko) 4-하이드록시부티릭산 고생성능을 가지는 변이 미생물 및 이를 이용한 4-하이드록시부티릭산의 제조방법
WO2015155790A3 (en) Production of lactic acid from organic waste or biogas or methane using recombinant methanotrophic bacteria
MY152746A (en) Altering enzyme balance through fermentation conditions
JP2010183921A5 (ja)
WO2010080782A3 (en) Random homozygous gene perburbation (rhgp) with thermal assymetric interlaced (tail)-pcr
WO2012136506A3 (de) Mikroorganismus und verfahren zur fermentativen herstellung einer organisch-chemischen verbindung